Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Pih24 - Modelled Effects of a Pediatric Triple-Chamber-Bag (3cb) System on Payer Costs and Clinical Outcomes in Pre-Term Neonates Across France, Germany and Italy

Value in Health

English

Pin46 - Cost-Effectiveness Comparison of Baloxavir Marboxil and Laninamivir for the Treatment of Influenza in Japan

English

Pcp23 - Does the European Union (Eu) Need European Hta or European Procurement?

English

Assessing the Comparative Outcomes From Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis

English

PMS1 Meta-Analisis De La Efectividad Y Seguridad Del Uso De Celecoxib en El Manejo Del Dolor Cronico vs Otros Cox-2 en Pacientes Con Osteartritis O Artritis Reumatoide

English

Pms36 - Switch Patterns and Total Healthcare Costs in Biologic-Naive Patients Initiating Apremilast or a Biologic for the Treatment of Psoriatic Arthritis: Results From a Us Claims Analysis

English

Prm38 - How Much Is Your Life Worth? Defining What the Willingness to Pay for a Qaly Is and Should Be

English

Pmh51 - Healthcare Resource Utilization and Costs Among Community-Dwelling Subjects With Schizophrenia Treated With RBP-7000 in a Clinical Trial Setting Over 12 Months

English

Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?

English

Psy20 - Real World Treatment Persistance of Golimumab in the Management of Immune-Mediated Rheumatic Diseases (Imrds) in Europe: A Systematic Literature Review (Slr)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Pih24 - Modelled Effects of a Pediatric Triple-Chamber-Bag (3cb) System on Payer Costs and Clinical Outcomes in Pre-Term Neonates Across France, Germany and Italy

Pin46 - Cost-Effectiveness Comparison of Baloxavir Marboxil and Laninamivir for the Treatment of Influenza in Japan

Pcp23 - Does the European Union (Eu) Need European Hta or European Procurement?

Assessing the Comparative Outcomes From Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis

PMS1 Meta-Analisis De La Efectividad Y Seguridad Del Uso De Celecoxib en El Manejo Del Dolor Cronico vs Otros Cox-2 en Pacientes Con Osteartritis O Artritis Reumatoide

Pms36 - Switch Patterns and Total Healthcare Costs in Biologic-Naive Patients Initiating Apremilast or a Biologic for the Treatment of Psoriatic Arthritis: Results From a Us Claims Analysis

Prm38 - How Much Is Your Life Worth? Defining What the Willingness to Pay for a Qaly Is and Should Be

Pmh51 - Healthcare Resource Utilization and Costs Among Community-Dwelling Subjects With Schizophrenia Treated With RBP-7000 in a Clinical Trial Setting Over 12 Months

Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?

Psy20 - Real World Treatment Persistance of Golimumab in the Management of Immune-Mediated Rheumatic Diseases (Imrds) in Europe: A Systematic Literature Review (Slr)